Elsy Boglioli Hofman
Director/Board Member at GENSIGHT BIOLOGICS S.A.
Net worth: 319 641 $ as of 2024-03-30
Profile
Ms. Elsy Boglioli Hofman is an Independent Director at FTI Consulting, Inc., a Chairman at Threefrog Therapeutics, an Independent Director at OSE Immunotherapeutics SA, an Independent Director at Gensight Biologics SA, a Chief Executive Officer at Bio-Up, an Advisor at Bluestone Venture Partners LLC and a Chief Strategy Officer & Director at Laverock Therapeutics Ltd.
She is on the Board of Directors at FTI Consulting, Inc., Wolf-Medizintechnik GmbH, Inova Software SA, OSE Immunotherapeutics SA, Gensight Biologics SA, METAFORA Biosystems SAS and Laverock Therapeutics Ltd.
Ms. Boglioli Hofman was previously employed as a Chief Operating Officer by Cellectis SA and a Managing Director & Partner by Boston Consulting Group SAS.
She received her undergraduate degree from Ecole Polytechnique and a graduate degree from Universitat Pompeu Fabra.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FTI CONSULTING, INC.
0.00% | 2023-06-06 | 1,520 ( 0.00% ) | 319 641 $ | 2024-03-30 |
Elsy Boglioli Hofman active positions
| Companies | Position | Start |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Director/Board Member | 2020-09-30 |
| OSE IMMUNOTHERAPEUTICS | Director/Board Member | 2021-06-23 |
| FTI CONSULTING, INC. | Director/Board Member | 2023-04-06 |
| Bio-Up | Chief Executive Officer | 2019-08-31 |
Bluestone Venture Partners LLC
 Bluestone Venture Partners LLC Investment ManagersFinance Bluestone Venture Partners LLC (Bluestone Venture Partners) is an independent venture capital firm founded in 2017 by Mara G. Aspinall and Tom Nickoloff. The firm is headquartered in Santa Fe, New Mexico. | Consultant / Advisor | 2017-11-30 |
Inova Software SA
 Inova Software SA Packaged SoftwareTechnology Services Inova Software SA develops management software solutions for biopharmaceutical companies. It offers search & evaluation, opportunities tracking, alliance management, mobile access, reporting and security & performance management software solutions. The company was founded by Gilles Toulemonde, Fritz Eisenhart, and David Carteret in 2010 and is headquartered in Villeurbanne, France. | Director/Board Member | 2021-06-30 |
METAFORA Biosystems SAS
 METAFORA Biosystems SAS BiotechnologyHealth Technology METAFORA Biosystems SAS is a French company that has received a €3.2 million grant from the European Commission's H2020 SME Instrument program. The company is based in Paris, France. The grant will allow the company to launch a large-scale prospective validation study of the METAglut1 test, which helps in the early diagnosis of De Vivo disease, a rare and under-diagnosed disease. The company has also received exceptional reimbursement for the METAglut1 test. The CEO of the company is Romain Kaspereit. | Director/Board Member | 2020-08-31 |
| Threefrog Therapeutics | Chairman | 2022-03-31 |
Wolf-Medizintechnik GmbH
 Wolf-Medizintechnik GmbH Medical DistributorsDistribution Services Wolf-Medizintechnik GmbH provides services in the fields of x-ray technology and electro medicine. It develops and manufactures systems for superficial and orthovoltage x-ray therapy and special systems used in medicine and non-destructive testing. It also distributes diagnostic x-ray equipment and provides technical and maintenance services. The company was founded in 1990 and is headquartered in St. Gangloff, Germany. | Director/Board Member | 2022-02-28 |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Elsy Boglioli Hofman
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Elsy Boglioli Hofman
| Universitat Pompeu Fabra | Graduate Degree |
| Ecole Polytechnique | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| FTI CONSULTING, INC. | Commercial Services |
| CELLECTIS S.A. | Health Technology |
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 8 |
|---|---|
Boston Consulting Group SAS
 Boston Consulting Group SAS Miscellaneous Commercial ServicesCommercial Services Boston Consulting Group SAS operates as a management consulting firm. It provides business and other consultancy services. The company is headquartered in Paris, France. | Commercial Services |
Inova Software SA
Inova Software SA Packaged SoftwareTechnology Services Inova Software SA develops management software solutions for biopharmaceutical companies. It offers search & evaluation, opportunities tracking, alliance management, mobile access, reporting and security & performance management software solutions. The company was founded by Gilles Toulemonde, Fritz Eisenhart, and David Carteret in 2010 and is headquartered in Villeurbanne, France. | Technology Services |
Wolf-Medizintechnik GmbH
Wolf-Medizintechnik GmbH Medical DistributorsDistribution Services Wolf-Medizintechnik GmbH provides services in the fields of x-ray technology and electro medicine. It develops and manufactures systems for superficial and orthovoltage x-ray therapy and special systems used in medicine and non-destructive testing. It also distributes diagnostic x-ray equipment and provides technical and maintenance services. The company was founded in 1990 and is headquartered in St. Gangloff, Germany. | Distribution Services |
Bluestone Venture Partners LLC
Bluestone Venture Partners LLC Investment ManagersFinance Bluestone Venture Partners LLC (Bluestone Venture Partners) is an independent venture capital firm founded in 2017 by Mara G. Aspinall and Tom Nickoloff. The firm is headquartered in Santa Fe, New Mexico. | Finance |
METAFORA Biosystems SAS
METAFORA Biosystems SAS BiotechnologyHealth Technology METAFORA Biosystems SAS is a French company that has received a €3.2 million grant from the European Commission's H2020 SME Instrument program. The company is based in Paris, France. The grant will allow the company to launch a large-scale prospective validation study of the METAglut1 test, which helps in the early diagnosis of De Vivo disease, a rare and under-diagnosed disease. The company has also received exceptional reimbursement for the METAglut1 test. The CEO of the company is Romain Kaspereit. | Health Technology |
| Bio-Up | |
| Threefrog Therapeutics | |
Laverock Therapeutics Ltd.
 Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | Health Technology |
- Stock Market
- Insiders
- Elsy Boglioli Hofman
